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Introduction
============

Lumbar interbody fusion has been suggested as a treatment option for chronic low back pain (CLBP) associated with single-level degenerative disc disease (DDD) \[[@REF1]-[@REF4]\]. Through the removal of the degenerated disc as a potential pain generator and fusion of the adjacent vertebrae, the surgery aims to reduce hypermobility and microinstability, hence mitigating pain stimuli \[[@REF1],[@REF5]-[@REF6]\]. In particular, anterior lumbar interbody fusion (ALIF) has been highlighted as a promising surgical technique, since the minimum clinically important difference (MCID) in patient-reported outcomes (PROMs) can be achieved with minimal blood loss and relatively short surgical times \[[@REF1]-[@REF4]\].

The surgical treatment of CLBP due to DDD through lumbar fusion has been controversial, as it has been suggested that surgical therapy is not necessarily better than conservative therapy in the general patient population \[[@REF7]\]. However, it has been observed that through thorough patient selection, the chances of successful treatment with interbody fusion are substantially improved, indicating that there are in fact subsets of patients that truly profit from surgery \[[@REF1],[@REF8]\]. Especially a positive outcome of the Pantaloon Cast Test (PCT), a cast worn for a certain period of time to increase stability and therefore imitate a spinal fusion, has served as a suitable prognostic test in determining likely successful surgery in patients who have not improved through long-term conservative therapy \[[@REF1],[@REF8]\].

Although there have been quite a few studies published on ALIF for CLBP, there is still a shortage of data regarding the safety of short-stay and outpatient ALIF procedures \[[@REF9]\]. Enhanced recovery after surgery (ERAS) protocols \[[@REF10]\] have also only been scarcely applied to ALIF \[[@REF11]-[@REF12]\]. Questions may be asked on outcomes and complication rates of carrying out such procedures in these settings \[[@REF9]\]. Hence, using data from a prospective registry, we aim to evaluate the safety and efficacy of ALIF for single-level DDD in a short-stay setting, as well as to identify predictors of surgical success.

Materials and methods
=====================

Overview

From a prospective registry, all patients who underwent elective ALIF for single-level DDD were identified. All patients were operated between March 2012 and February 2019 in a multidisciplinary team including a neurosurgeon (M.L.S.) and access surgeon (J.W.A.O.) at a specialized short-stay spine surgery clinic. Patients underwent ALIF according to the modified technique by Brau as described previously \[[@REF1]\]. An ERAS protocol \[[@REF9]\] was applied to improve rehabilitation after surgery, consisting of among others a strict preoperative screening and counseling for suitability of surgical treatment in this setting, thorough preoperative patient education, use of a mini-open technique and autologous cell saver transfusion, limited use of muscle relaxants during surgery, intraoperative avoidance of hypothermia, hypotension, and fluid disbalance, effective and early postoperative analgesia, early guided mobilization and elastic bracing, no restriction on activities of daily living (ADL) postoperatively, and regular, systematic audits \[[@REF9],[@REF13]-[@REF14]\] (Table [1](#TAB1){ref-type="table"}).

###### Elements of the institutional Enhanced Recovery after Surgery (ERAS) protocol

BMI, body mass index; MI, minimally invasive; MI-PLIF, MI posterior lumbar interbody fusion; NSAIDs, non-steroidal anti-inflammatory drugs.

  ---------------- ----------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------
  Timepoint        Element                                                                       Summary                                                                                                                                                                       Discipline
  Preoperative                                                                                                                                                                                                                                                                  
  1                Control of smoking and alcohol intake                                         Advice to cease smoking and excessive alcohol intake before surgery; Cessation of smoking 3 months before fusion surgery                                                      Neurosurgeon
  2                Strict patient screening                                                      Strict anesthesiologic screening and patient selection to enhance perioperative patient safety by targeted optimization of comorbidities                                      Anesthesiologist
  3                Weight loss in obese patients                                                 Structured nutritional advice and counseling for patients with a BMI \> 30                                                                                                    Multidisciplinary
  4                Patient education                                                             Systematic education on what to expect during recovery. Three simple principles of conduct are provided ("Three Golden Rules")                                                Neurosurgeon
  5                Prophylaxis against infection                                                 Prophylaxis using a broad-spectrum antibiotic                                                                                                                                 Anesthesiologist
  6                Prophylaxis against thrombosis                                                Prophylaxis using low molecular weight heparin                                                                                                                                Anesthesiologist
  Intraoperative                                                                                                                                                                                                                                                                
  7                Standardized anesthesia and avoidance of long-acting opioids                  General anesthesia was maintained using propofol and a short-acting opioid                                                                                                    Anesthesiologist
  8                Local analgesia                                                               Infiltration of the surgical site with local analgesic agents, when applicable                                                                                                Neurosurgeon
  9                Minimally-invasive surgical techniques                                        By use of tubular working channels, robotic guidance, and MI or mini-open approaches, large incisions and therefore damage to muscles can be reduced                          Neurosurgeon
  10               Limited use of muscle relaxants                                               Muscle relaxants were only sparingly used to enable more efficient mobilization and recovery                                                                                  Anesthesiologist
  11               Prevention of fluid dysbalance and blood transfusion                          Over- or underhydration was minimized, vasopressors were administered to regulate blood pressure, and autologous cell-saver transfusion was available during all procedures   Anesthesiologist
  12               Prevention of hypothermia                                                     Body temperature was controlled using warm air blankets                                                                                                                       Anesthesiologist
  Postoperative                                                                                                                                                                                                                                                                 
  13               Sparing use and early removal of surgical site drains and urinary catheters   Surgical site drains were only used after mini-open decompression or MI-PLIF. Both drains and catheters were removed as early as possible                                     Multidisciplinary
  14               Opioid-sparing analgesia                                                      Effective analgesia was achieved using NSAIDs and paracetamol. Patient-controlled analgesia with short-acting opioids was avoided                                             Multidisciplinary
  15               Early mobilization                                                            Whenever feasible, patients were mobilized two hours after surgery under guidance of a physical therapist                                                                     Physical Therapist
  16               Early intake of solids and fluids                                             Patients were encouraged to ingest oral solids and fluids at will on the day of surgery                                                                                       Multidisciplinary
  17               Preparation for early discharge                                               Integration of relatives and early organization of transport allowed patients to be discharged home early after a minimum one-night stay                                      Multidisciplinary
  Post-discharge                                                                                                                                                                                                                                                                
  18               Minimal restriction of activities of daily living (ADL)                       No restrictions in ADL were set                                                                                                                                               Neurosurgeon
  19               Patient-friendly website with frequently asked questions (FAQ)                Patients are provided with a website that includes a range of FAQ as well as detailed information on the recovery process                                                     Multidisciplinary
  20               Scheduled early follow-up by phone                                            Two days and two weeks after surgery, patients are called to check on the status of their recovery process                                                                    Neurosurgeon
  21               Low threshold for clinical follow-up visit/readmission                        Patients were instructed to call in 24/7 with any uncertainties. If desired by the patient, a low threshold for a clinical follow-up visit or readmission was set             Multidisciplinary
  22               Regular digital audit/follow-up                                               At 6 weeks, 12 months, and 24 months, questionnaires were automatically dispatched to patients digitally, allowing for effective follow-up                                    Multidisciplinary
  ---------------- ----------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------

Ethical considerations

This institutional registry was approved by the local institutional review board (Medical Research Ethics Committees United, Registration Number: W16.065), and this study was performed according to the Declaration of Helsinki. All individual patients in this study provided written informed consent. This study was compiled according to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement \[[@REF15]\].

Patient selection

Only patients with single-level DDD on magnetic resonance imaging (MRI) presenting with severe, intractable low back pain were considered for ALIF. The decision of a minimally invasive posterior versus anterior approach was made based upon suitable index levels, the desire to avoid the risk of impaired fertility due to the potential complication of retrograde ejaculation, and absence of spondylolisthesis. To be considered for surgical treatment, patients had to have completed ≥6 months of unsuccessful conservative treatment. Unless failed back surgery syndrome (FBSS) after at least two prior surgeries at the index level was present, patients had to undergo pantaloon cast testing (PCT) for two weeks, with a ≥50% improvement in back pain over at least 14 days to be considered for surgery \[[@REF1],[@REF8],[@REF16]\]. Provocative discography and disco-block were not regularly used \[[@REF1],[@REF17]-[@REF21]\]. Modic type endplate changes were routinely captured, but had no influence on surgical decision-making.

Preoperative anesthesiologic screening

We applied strict selection criteria for patients considered for surgical treatment \[[@REF22]-[@REF23]\]. A very thorough anesthesiologic screening was carried out for all patients. Patients aged \>80 or with a body mass index (BMI) \>35, or American Society of Anesthesiologists (ASA) score \>2 were not eligible for surgery \[[@REF24]\]. These limitations are dictated by the local insurance policy. Sleep Apnea Syndrome was also a contraindication for surgery. Patients on anticoagulants were never considered for surgery in our setting. This is due to the often-associated comorbidities, and the risk of major bleeding, which represent a high surgical risk without having intensive care unit (ICU) facilities as a back-up. However, patients who were solely on acetylsalicylic acid were considered, and were allowed to continue medication perioperatively. Strict blood pressure regulation was maintained. Patients with hypertension at the preoperative screening were required to consult with their general practitioner or cardiologist to regulate blood pressure before being considered for surgery. Patients were required to cease smoking before being scheduled for fusion surgery. Osteoporosis was a contraindication for fusion procedures \[[@REF25]\]. Patients who presented with a higher risk profile than delineated by our screening thresholds were always referred to larger, academic or community hospitals.

Perioperative management

Preoperatively, patients received cefazolin (2000 mg) as antibiotic prophylaxis, and general anesthesia was maintained using propofol and sufentanil. The use of muscle relaxants was limited to allow for faster recovery. Autologous cell-saver transfusion was available during all procedures \[[@REF26]\]. Postoperatively, analgesia was maintained and adjusted as appropriate. All patients were mobilized early on the day of surgery under the guidance of a licensed physiotherapist and were discharged home as soon as they were able to climb stairs. Patients were provided with a light elastic brace. No restrictions on ADL were made, and patients were instructed to contact the center with any uncertainties. Patients were seen for a six-week and one-year follow-up.

Data collection

Patients completed a standardized questionnaire containing a visual analogue scale (VAS) for back pain and leg pain severity, and a validated Dutch version of the Oswestry Disability Index (ODI) as a measure of functional disability. The ODI at 12 months was defined as the primary endpoint. Patients filled in paper-based questionnaires at baseline. At six weeks and 12 months after surgery, scheduled follow-up questionnaires were obtained during the subsequent visits. All complications were systematically collected in a separate database, and reoperations were tracked.

Statistical analysis

Continuous data are given as mean ± standard deviation, and categorical data as numbers (percentages). Clinical success was defined as reaching the MCID of ≥30% improvement in ODI - the primary endpoint of this study - from baseline to the 12-month follow-up \[[@REF27]\]. Mann-Whitney U and χ2 tests were performed to assess intergroup differences, depending on the data type. Intra-subject longitudinal data were assessed using Wilcoxon's signed-rank test. All analyses were carried out using R version 3.5.1 (The R Foundation for Statistical Computing, Vienna, Austria). A 2-tailed p ≤ 0.05 was considered statistically significant.

Results
=======

Patient characteristics

In total, 44 patients were operated upon. The cohort included 15 (33%) male and 30 (67%) female patients, with the average age being 40.8 years, ranging from 19 to 62 years (Table [2](#TAB2){ref-type="table"}).

###### Summary of patient demographics

SD, standard deviation; DDD, degenerative disc disease; PCT, pantaloon cast test; BMI, body mass index; PROM, patient-reported outcome measure; VAS, visual analogue scale; ODI, Oswestry Disability Index.

  ------------------------------------------ ----------------
  Parameter                                  Value (N = 44)
  Age, mean ± SD \[yrs.\]                    40.8 ± 8.8
  Male gender, n (%)                         15 (33)
  Modic type endplate changes, n (%)          
  None                                       8/39 (20)
  1                                          23/39 (59)
  2                                          8/39 (20)
  Single-level DDD, n (%)                    30/39 (77)
  Received PCT, n (%)                        33 (73)
  Positive PCT, n (%)                        31/33 (96)
  Prior surgery, n (%)                       17/40 (43)
  Active smoker, n (%)                       12/41 (29)
  Height, mean ± SD \[m\]                    1.77 ± 0.099
  Weight, mean ± SD \[kg\]                   76 ± 11.4
  BMI, mean ± SD \[kg/m^2^\]                 24.3 ± 2.6
  History of back pain, mean ± SD \[mos.\]   11.2 ± 3.5
  Index level, n (%)                          
  L3-L4                                      1 (2)
  L4-L5                                      23 (51)
  L5-S1                                      20 (42)
  L4-S1                                      1 (2)
  Baseline PROMs, mean ± SD                   
  VAS Back Pain                              71.8 ± 19.5
  VAS Leg Pain                               42.9 ± 28.4
  ODI                                        49.1 ± 14.6
  ------------------------------------------ ----------------

Efficacy

###### Short- and long-term outcome measures

SD, standard deviation; VAS, visual analogue scale; ODI, Oswestry Disability Index; MCID, minimum clinically important difference.

  ------------------------------------------------ ----------------
  Parameter                                        Value (N = 44)
  6-week PROM scores, mean ± SD                     
  VAS Back pain                                    32.7 ± 22.4
  VAS Leg pain                                     23.9 ± 30.5
  ODI                                              29.5 ± 18.4
  12-month PROM scores, mean ± SD                   
  VAS Back pain                                    31.4 ± 26.8
  VAS Leg pain                                     17.9 ± 22.8
  ODI                                              20.1 ± 18.2
  12-month change score from baseline, mean ± SD    
  VAS Back pain                                    42.6 ± 30.5
  VAS Leg pain                                     20.7 ± 32.8
  ODI                                              28.5 ± 22.7
  MCID, n (%)                                      21/27 (78)
  ------------------------------------------------ ----------------

Twenty-seven patients (61%) had full data on baseline and 12-month PROMs. Clinical success was met in 21 patients, while it was not achieved in 6 patients, resulting in a clinical success rate of 78% (Table [3](#TAB3){ref-type="table"}).

No differences were found regarding gender, age, presence of Modic changes, prior surgery or smoking status (Table [4](#TAB4){ref-type="table"}).

###### Analysis of factors potentially associated with MCID in the primary endpoint

\* p ≤ 0.05

MCID, minimum clinically important difference.

  ----------------------- ------------ -------------- ------
                          MCID                        
  Parameter               NO (N = 6)   YES (N = 21)   P
  Gender, n (%)                                       1.0
  Male                    2 (33)       7 (33)          
  Female                  4 (67)       14 (67)         
  Age, n (%)                                          0.27
  \> 45                   0 (0)        7 (33)          
  ≤ 45                    6 (100)      14 (67)         
  Modic Changes, n (%)                                1.0
  Yes                     4 (67)       15 (71)         
  No                      1 (17)       4 (19)          
  Prior surgery                                       0.32
  Yes                     2 (33)       9 (43)          
  No                      3 (50)       11 (52)         
  Discography, n (%)                                  0.62
  Positive                4 (67)       12 (57)         
  Negative                0 (0)        3 (14)          
  Smoking Status, n (%)                               1.0
  Smoker                  2 (33)       6 (29)          
  Non-Smoker              3 (50)       14 (63)         
  ----------------------- ------------ -------------- ------

:Table [5](#TAB5){ref-type="table"} lists all factors that were tested in association with PROM change scores. Out of all factors, only the association of age with ODI change score was proven to be statistically significant (p = 0.03), showing greater change scores in patients above the age of 45. Apart from that, neither gender, Modic changes, prior surgery or smoking status had an influence on the PROM change scores.

###### Analysis of factors potentially associated with PROM change scores

\* p ≤ 0.05

PROM, patient-reported outcome measure; SD, standard deviation; VAS, visual analogue scale; ODI, Oswestry Disability Index; MCID, minimum clinically important difference.

  ---------------- --------------------------- ---------- ------------- ------ ------------- ------
  Parameter                     Change Score                                                 
                   ODI                         VAS BP     VAS LP                             
                   Mean ±  SD                  P          Mean ± SD     P      Mean ±  SD    P
  Gender                                                                                      
  Male             27.3 ± 19.6                 0.98       36.7 ± 30.0   0.52   12.9 ± 40.7   0.76
  Female           28.5 ± 24.4                            45.5 ± 32.3          23.7 ± 30.1    
  Age                                                                                         
  \> 45            43.4 ± 14.7                 0.03\*     27.1 ± 35.9   0.16   21.4 ± 29.1   0.74
  ≤ 45             22.8 ± 22.6                            47.8 ± 27.5          20.4 ± 35.0    
  Modic Changes                                                                               
  Yes              29.4 ± 21.0                 0.94       46.7 ± 30.4   0.49   23.5 ± 33.0   0.89
  No               26.4 ± 21.0                            38.0 ± 25.6          26.7 ± 23.1    
  Prior Surgery                                                                               
  Yes              30 ± 17.1                   0.85       45.3 ± 36.4   0.70   20.8 ± 45.3   0.93
  No               29.6 ± 24.5                            37.7 ± 27.4          23.0 ± 23.1    
  Discography                                                                                 
  Positive         30.8 ± 25.4                 0.74       38.1 ± 35.0   1.00   12.3 ± 28.6   0.20
  Negative         32.0 ± 2.0                             43.3 ± 25.2          33.3 ± 11.5    
  Smoking Status                                                                              
  Smoker           29.5 ± 16.5                 0.95       44.4 ± 27.7   0.78   7.1 ± 30.4    0.10
  Non-Smoker       27.5 ± 23.6                            47.4 ± 28.6          31.7 ± 29.5    
  ---------------- --------------------------- ---------- ------------- ------ ------------- ------

Safety

We observed only one complication. Postoperative radiculopathy appeared in one patient (2.3%), but the issue resolved after six weeks. Aside from this none of the complications associated with ALIF, such as retrograde ejaculation, incisional hernia, or vascular injuries among others, were observed in this study.

Discussion
==========

In this evaluation of a prospective registry, among 44 patients undergoing ALIF for degenerative disc disease using an ERAS protocol in a short-stay setting, efficacy, and safety was assessed. Clinical success was achieved in a considerable number of patients, yielding an overall clinical success rate of 78% at 12 months postoperatively. Complications were held to a minimum with the appearance of only one transient complication.

Previously, a series of RCTs demonstrated that - in a general patient population with CLBP - fusion surgery is no better than conservative treatment \[[@REF7]\]. However, newer studies have shown that, while this finding certainly holds true in an unselected patient cohort, very strict patient selection can identify subsets of patients who truly profit from surgical treatment after years of unsuccessful conservative treatment \[[@REF1]\]. Lammli et al. \[[@REF4]\] found a significant decrease in pain and substantial functional improvements after the procedure. In addition, Kleimeyer et al. \[[@REF2]\] found a higher efficacy in selective ALIF than in nonsurgical treatment. With the satisfactory outcomes regarding the effectiveness of the procedure that this study yielded for CLBP - a pain syndrome notoriously hard to treat - our findings coincide with the current literature and suggest that ALIF is effective in carefully selected patients who have failed long-term conservative treatment and when surgery is strictly considered a "last resort".

A range of prognostic tools have been tested over the years. Apart from failed long-term conservative treatment, the PCT has shown to be the single most efficient prognostic test for outcome after surgery for CLBP, and has been independently verified to be so \[[@REF1],[@REF8]\]. A positive PCT is especially predictive in patients with single-level DDD without prior surgery \[[@REF1],[@REF8]\]. This effect may be explained in two ways: The PCT simulates a bony fusion by stabilizing the lumbar vertebrae, and the willingness to endure an uncomfortable pantaloon cast for two weeks indicating a certain "last resort" motivation. In this study, the predictive effects of a positive PCT, according to the definitions of its positivity (≥ 50% pain reduction), was not found by the obviously insufficient power of this specific analysis since 96% of surgically treated patients had a positive PCT. In contrast, discography has failed to show prognostic value in this patient population, and deleterious effects have even been demonstrated to occur after disc infiltration \[[@REF1],[@REF17]-[@REF20],[@REF28]\].

A low occurrence of complications in ALIF procedures, along with low morbidity have been reported by various studies \[[@REF2]-[@REF4],[@REF29]-[@REF30]\]. Additionally, the success and fusion rate of the procedure has been reported to be relatively high by many authors \[[@REF3]\]. Along with reports of shorter surgery times and lower blood loss, this substantiates the safety of ALIF procedures in a subset of the general DDD population. In light of the absence of a general or vascular surgeon, or intensive care unit in most short-stay settings, the multidisciplinary approach in partnership with a general or vascular surgeon cannot be underestimated.

While there generally is a consensus of the safety and efficacy of standalone ALIF with many studies showing similar outcomes, the results should nevertheless be interpreted with caution. Several authors have questioned the superiority of posterior spinal fusion in the long run \[[@REF7]\]. Giang et al. \[[@REF30]\] stated in a review of the current literature that while stand-alone ALIF is generally seen as effective, some key studies showed opposite results, fortifying the existing dissent on the topic.

ERAS protocols were first developed in colorectal surgery and have since been applied in a wide range of surgical specialties \[[@REF10]\]. In spine surgery, ERAS has been shown to reduce acute care costs, length of hospital stay, and postoperative pain \[[@REF9],[@REF12]-[@REF14]\]. The rationale of ERAS lies within the fact that its elements aim to (1) improve the preoperative state of the patient, (2) reduce the burden of surgery, and (3) stimulate fast recovery to ADL. In our series, our proprietary ERAS protocol has been applied \[[@REF9]\]. Although neither intergroup comparison to non-ERAS patients nor comparison to a historical control group was possible, our experience underlines the importance of a multidisciplinary team to streamline the recovery process. Foremost, this is essential in a short-stay setting, where reducing the burden of surgery can lead to massive patient and financial benefits over time, especially once the initial learning curve in implementation of the ERAS protocol has been completed \[[@REF9]\].

Limitations

This study was largely limited by the small sample size and partly incomplete data, which resulted in low statistical power. In addition, although this was not the focus of this study, the finding pertaining to prognostic factors may be less powerful due to the low sample size, and the one statistically significant finding may have been arrived at by multiple testing. However, all data stem from a prospective registry. All procedures were conducted in a single-center, which may lead to further bias. The results may not be applicable to all treatment groups since the patients were already highly selected on the grounds of a positive PCT, and hence the analysis regarding PROMs only concern subsets of the general surgical population. In a similar manner, our findings might not be applicable to older adults, since the dataset did not include patients above the age of 62.

Conclusions
===========

In this study, clinical success was achieved in a considerable number of patients with the occurrence of only one complication that resolved after six weeks. With these favorable outcomes, it can be suggested that standalone ALIF in a short-stay setting with application of an ERAS protocol is an effective and safe treatment for CLBP associated with DDD. Thus, it may be an option for strictly selected patients who may profit from surgery after failed long-term conservative therapy. A multidisciplinary approach, encompassing access surgery and anesthesiology, is crucially important to the procedure's safety and success in a short-stay setting.
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